Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This compound is designed to improve glycemic control by targeting both the GIP and GLP-1 receptors, potentially increasing insulin secretion while decreasing glucagon secretion in a glucose-dependent manner.
Clinical studies have demonstrated promising results regarding blood sugar regulation and weight management effects. The product is available in various concentrations to meet different research requirements.
Important Note: This product is synthesized chemically and is intended solely for research purposes. It is not approved for human consumption or medical use.
When storing peptides like semaglutide buy UK researchers should consider: Store in a cold, dry, dark environment; Avoid repeated freeze-thaw cycles; Minimize air exposure; Protect from light; Avoid long-term storage in solution; Aliquot according to experimental needs.
The product functions include: Slowing gastric emptying; Reducing hepatic glucose production; Stimulating glucose-dependent insulin secretion; Controlling blood glucose levels; Reducing postprandial hyperglycemia; Decreasing fasting insulin and glucose; Lowering hemoglobin A1c; Reducing appetite and caloric intake; Potentially aiding weight management.